Another breast cancer-related study demonstrated the role of JMJD6 amplification in tumor cells as cooperating with c-Myc, which leads to reduced p53 levels, tumor metastases, progression, and increased cellular transformation [64]. Here, JMJD6 is linked to breast cancer.